You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國衛生集團(00673.HK)預期2025財年虧損增加

格隆匯6月27日丨中國衛生集團(00673.HK)公告,公司預期將於2025財年錄得股東應佔虧損淨額約66,000,000港元至70,000,000港元,而2024財年則錄得股東應佔虧損淨額約40,200,000港元。

2025財年虧損增加乃主要由於以下因素所致:(i)上訴法院於2024年10月就CapitalForesightLimited(申索人)對公司提出支付4,000,000美元承兌票據的申索而對公司宣判的判決(沒有應付利息)產生的訴訟開支撥備4,000,000美元(2024財年:無)。申索已於2023年12月20日獲香港高等法院駁回,但於申索人上訴後,上訴法院已作出上訴判決;(ii)「其他應付款項撥回」賬目中的其他收入由2024財年約31,200,000港元減少約15,000,000港元至2025財年約16,300,000港元。於高等法院駁回前,申索一直入賬列作公司的「應付款項」。因此,於高等法院駁回後,於2024財年確認應付款項一次性撥回31,200,000港元。2025財年的應付款項撥回16,300,000港元指若幹其他應付款項撥回總額,乃由於(a)相關債權人根據適用法律及合約向法院提出付款申索的時效已屆滿;或(b)已取得相關債權人的付款豁免所致;(iii)2025財年的毛利減少約4,400,000港元至約9,200,000港元(2024財年:約13,600,000港元);及(iv)上述負面因素部分被2025財年銷售、分銷及行政費用(不包括上文(i)段所述訴訟開支撥備)合共減少約14,700,000港元至約37,000,000港元(2024財年:約51,700,000港元)所抵銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account